WallStreetZenWallStreetZen

NASDAQ: XBIO
Xenetic Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their XBIO stock forecasts and price targets.

Forecast return on equity

Is XBIO forecast to generate an efficient return?

Company
-12.32%
Industry
153.19%
Market
81.87%
XBIO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is XBIO forecast to generate an efficient return on assets?

Company
-10.73%
Industry
36.07%
XBIO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

XBIO earnings per share forecast

What is XBIO's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$3.24
Avg 2 year Forecast
-$0.45
Avg 3 year Forecast
-$0.54

XBIO revenue forecast

What is XBIO's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$2.8M+11.99%
Avg 2 year Forecast
$2.3M-8.01%
Avg 3 year Forecast
$2.5M-0.01%
XBIO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

XBIO revenue growth forecast

How is XBIO forecast to perform vs Biotechnology companies and vs the US market?

Company
-1.58%
Industry
65.48%
Market
10.37%
XBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XBIO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
XBIO$2.44N/AN/A
TCRT$2.35N/AN/A
JAGX$5.63N/AN/A
DRMA$0.71N/AN/A
WINT$1.08$7.00+548.15%Hold
View Top Biotech Stocks

Xenetic Biosciences Stock Forecast FAQ

What is XBIO's earnings growth forecast for 2025-2027?

(NASDAQ: XBIO) Xenetic Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.

Xenetic Biosciences's earnings in 2025 is -$3,960,275.On average, 1 Wall Street analyst forecast XBIO's earnings for 2025 to be -$4,996,530, with the lowest XBIO earnings forecast at -$4,996,530, and the highest XBIO earnings forecast at -$4,996,530. On average, 1 Wall Street analyst forecast XBIO's earnings for 2026 to be -$693,963, with the lowest XBIO earnings forecast at -$693,963, and the highest XBIO earnings forecast at -$693,963.

In 2027, XBIO is forecast to generate -$832,755 in earnings, with the lowest earnings forecast at -$832,755 and the highest earnings forecast at -$832,755.

If you're new to stock investing, here's how to buy Xenetic Biosciences stock.

What is XBIO's revenue growth forecast for 2025-2027?

(NASDAQ: XBIO) Xenetic Biosciences's forecast annual revenue growth rate of -1.58% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.37%.

Xenetic Biosciences's revenue in 2025 is $2,500,284.On average, 1 Wall Street analysts forecast XBIO's revenue for 2025 to be $4,317,989, with the lowest XBIO revenue forecast at $4,317,989, and the highest XBIO revenue forecast at $4,317,989. On average, 1 Wall Street analysts forecast XBIO's revenue for 2026 to be $3,546,920, with the lowest XBIO revenue forecast at $3,546,920, and the highest XBIO revenue forecast at $3,546,920.

In 2027, XBIO is forecast to generate $3,855,348 in revenue, with the lowest revenue forecast at $3,855,348 and the highest revenue forecast at $3,855,348.

What is XBIO's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: XBIO) forecast ROA is -10.73%, which is lower than the forecast US Biotechnology industry average of 36.07%.

What is XBIO's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: XBIO) Xenetic Biosciences's current Earnings Per Share (EPS) is -$2.57. On average, analysts forecast that XBIO's EPS will be -$3.24 for 2025, with the lowest EPS forecast at -$3.24, and the highest EPS forecast at -$3.24. On average, analysts forecast that XBIO's EPS will be -$0.45 for 2026, with the lowest EPS forecast at -$0.45, and the highest EPS forecast at -$0.45. In 2027, XBIO's EPS is forecast to hit -$0.54 (min: -$0.54, max: -$0.54).

What is XBIO's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: XBIO) forecast ROE is -12.32%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.